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RocA Binds CsrS To Modulate CsrRS-Mediated Gene
Regulation in Group A Streptococcus
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aDivision of Infectious Diseases, Boston Children’s Hospital, Boston, Massachusetts, USA
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ABSTRACT The orphan regulator RocA plays a critical role in the colonization and
pathogenesis of the obligate human pathogen group A Streptococcus. Despite multi-
ple lines of evidence supporting a role for RocA as an auxiliary regulator of the con-
trol of virulence two-component regulatory system CsrRS (or CovRS), the mechanism
of action of RocA remains unknown. Using a combination of in vitro and in vivo
techniques, we now ﬁnd that RocA interacts with CsrS in the streptococcal mem-
brane via its N-terminal region, which contains seven transmembrane domains. This
interaction is essential for RocA-mediated regulation of CsrRS function. Furthermore,
we demonstrate that RocA forms homodimers via its cytoplasmic domain. The
serotype-speciﬁc RocA truncation in M3 isolates alters this homotypic interaction, re-
sulting in protein aggregation and impairment of RocA-mediated regulation. Taken
together, our ﬁndings provide insight into the molecular requirements for functional
interaction of RocA with CsrS to modulate CsrRS-mediated gene regulation.
IMPORTANCE Bacterial two-component regulatory systems, comprising a membrane-
bound sensor kinase and cytosolic response regulator, are critical in coordinating the
bacterial response to changing environmental conditions. More recently, auxiliary
regulators which act to modulate the activity of two-component systems, allowing
integration of multiple signals and ﬁne-tuning of bacterial responses, have been
identiﬁed. RocA is a regulatory protein encoded by all serotypes of the important
human pathogen group A Streptococcus. Although RocA is known to exert its regula-
tory activity via the streptococcal two-component regulatory system CsrRS, the
mechanism by which it functions was unknown. Based on new experimental evi-
dence, we propose a model whereby RocA interacts with CsrS in the streptococcal
cell membrane to enhance CsrS autokinase activity and subsequent phosphotransfer
to the response regulator CsrR, which mediates transcriptional repression of target
genes.
KEYWORDS Streptococcus pyogenes, gene regulation, pathogenesis, regulatory
proteins, virulence
Regulation of virulence factor production is integral to bacterial survival and patho-genesis. A major mechanism by which bacteria detect and respond to environ-
mental cues involves the integration of signals from two-component regulatory sys-
tems (TCS) (1). While many variations exist, these systems typically comprise a
membrane-bound sensor kinase and a cognate cytoplasmic response regulator, the
activity of which is modulated by phosphorylation (1). Environmental signals stimulate
or inhibit auto-kinase activity of the sensor and downstream phosphorylation of the
response regulator.
Thirteen TCS have been identiﬁed in the important human pathogen group A
Streptococcus (Streptococcus pyogenes or GAS). Among these, CsrRS (also known as
CovRS), has been shown to play a critical role in streptococcal colonization and disease
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pathogenesis by regulating the expression of 10% of the GAS genome, including
genes encoding several key virulence factors (2–6). Naturally occurring loss-of-function
mutations in CsrRS have been identiﬁed in up to 40% of invasive disease isolates (7–9).
The increased virulence of such strains has been attributed to derepression of tran-
scription of CsrRS-regulated virulence factors, such as the hyaluronic acid capsule and
the cotranscribed toxins NAD glycohydrolase (NADase) and streptolysin O (4).
Two environmental signals have been shown to regulate expression of genes in the
CsrRS regulon: extracellular magnesium concentration and the human antimicrobial
peptide LL-37 (6, 10–12). Exposure of GAS to elevated concentrations of Mg2 stimu-
lates phosphorylation of CsrR in a CsrS-dependent manner and results in repression of
most CsrRS-regulated genes (6, 13). LL-37 has been shown to bind to CsrS in vitro (14),
and exposure of GAS to subinhibitory concentrations of LL-37 results in reduced
phosphorylation of CsrR and increased expression of the same genes that are repressed
by Mg2 (11, 12, 15).
Auxiliary regulators that interact with TCS to form multicomponent signal transduc-
tion systems have been identiﬁed in several bacterial species (16–21). These proteins
integrate diverse inputs to modulate TCS by direct protein-protein interactions, which
ultimately dictate the phosphorylation state of the response regulator and subsequent
transcriptional regulation of target genes (19). Auxiliary proteins can act in a variety of
ways on either the sensor kinase or the response regulator. Different classes of auxiliary
regulators include accessory phosphatases, such as the Escherichia coli protein CheZ,
which dephosphorylates the response regulator CheY (20), and antikinases, such as the
Bacillus subtilis protein KipI, which inhibits the kinase activity of the histidine kinase
KinA via the catalytic domain (21). Other membrane-bound regulators have been
shown to interact with the transmembrane domains (TMDs) of histidine kinases to
modulate either kinase or phosphatase activity, examples of which include the group
B streptococcal protein Abx1, which impedes the kinase activity of CsrS (16).
The orphan regulator RocA was originally identiﬁed as a positive regulator of the
CsrRS TCS (22). More recent studies suggest that RocA acts as an auxiliary regulator of
CsrRS, a hypothesis supported by transcriptome sequencing (RNA-seq) experiments
showing the RocA regulon to be entirely included within that of CsrRS (23–25). Indeed,
naturally occurring mutations in RocA result in derepression of CsrRS-regulated viru-
lence genes and enhanced virulence of the affected strains (23, 25, 26). Such mutations
or deletion of RocA results in reduced phosphorylation of CsrR, which, in turn, is
thought to relieve the repression of CsrRS-regulated gene expression (23). Mg2 retains
its regulatory effect on the CsrRS regulon in a RocA mutant, but LL-37 does not (27).
These observations are consistent with a model in which, in a RocA mutant, phosphor-
ylation of CsrR can be increased through the interaction of Mg2 with CsrS. However,
since CsrR is maximally dephosphorylated at baseline in a RocA mutant, it cannot be
further dephosphorylated through the action of LL-37.
Despite a clear role for RocA in modulating CsrRS-mediated regulation in GAS,
conserved, M-type-speciﬁc, nonsense mutations in rocA have been identiﬁed in all
tested isolates of two important serotypes, M3 (23, 28) and M18 (26). These mutations
have been shown to impair CsrRS-mediated gene regulation, thereby increasing pro-
duction of the hyaluronic acid capsule and other CsrRS-regulated virulence factors (23,
26–28). The M18-speciﬁc truncation occurs very early in the RocA protein (amino acid
29 of 451) (26), and no protein fragment is thought to be expressed. In contrast,
truncated M3 RocA protein, which results from a frameshift mutation at codon 410 and
a subsequent premature stop codon at position 416, is not functional (23, 28). Com-
plementation of rocA of serotype M18 strains (rocAM18) or rocAM3 with a single copy of
the full-length gene is sufﬁcient to restore CsrRS regulatory control (23, 26, 28).
Interestingly, overexpression of RocAM3 in a RocA-negative background restored CsrRS
regulatory activity, suggesting that multiple copies of this truncated protein are sufﬁ-
cient to overcome its structural or conformational defects in modulating CsrRS activity
(27). Until now, the mechanism by which RocAM3 activity is impaired has not been
described.
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To better understand the functional relationship between RocA and CsrRS, we
investigated the physical association between these two proteins. RocA is a transmem-
brane protein predicted to be comprised of seven N-terminal TMDs and a C-terminal
cytoplasmic domain (CYT) that includes a putative ATPase motif (22). Experiments using
strains expressing deﬁned fragments of RocA revealed that the C terminus was neces-
sary and sufﬁcient for RocA homodimerization. However, the cytoplasmic domain alone
was not sufﬁcient to restore RocA modulation of CsrRS regulation in a RocA-deﬁcient
GAS strain. Using a combination of coimmunoprecipitation in GAS and Lactococcus
lactis, we found evidence for a direct interaction between the membrane-associated
N-terminal domain of RocA and CsrS. Our data support a model in which RocA binding
to CsrS potentiates CsrS autokinase activity and/or inhibits its phosphatase activity,
enhancing downstream phosphorylation of CsrR to regulate virulence gene expression.
RESULTS
RocA transmembrane domains are sufﬁcient to modulate phosphorylation of
CsrR- and CsrRS-regulated gene expression. Previous reports identify RocA as a
membrane-associated protein based on analysis with protein prediction software (24,
27), which we conﬁrmed using TMPred (29) (Fig. 1A). However, membrane localization
of RocA has not been proven in vivo. Accordingly, we investigated the subcellular
location of RocA. Native expression of RocA within GAS is very low, so to facilitate
FIG 1 Characterization of GAS strains expressing full-length RocA or RocA fragments. (A) Schematic representation of RocA protein. The region of RocA
containing transmembrane domains (TMDs; amino acids 1 to 225) is highlighted in blue, and the cytoplasmic domain (CYT; amino acids 225 to 451) is
highlighted in purple. Red numbers denote sites of M3 (amino acid 416)- and M18 (amino acid 29)-speciﬁc truncations. RocA fragments expressed in plasmid
pDL278 are shown schematically below. HATPase, histidine kinase-like ATPase. (B) Western blot of membrane fractions of GAS M18 strains expressing speciﬁc
RocAFLAG fragments probed with anti-FLAG antibody. Lanes C, cytosolic fraction; lanes M, membrane fraction. Numbers at the left are molecular masses (in
kilodaltons). (C) Quantiﬁcation of capsular hyaluronic acid of GAS M18 strains expressing RocAFLAG fragments. (D) Western blot for CsrR in GAS lysates separated
on 10% Phos-tag polyacrylamide gels for the strains indicated above each lane. CsrR-P denotes phosphorylated CsrR protein. T284A and H280A CsrS mutant
GAS strains served as controls (the T284A strain for phosphorylated CsrR and the heated T284A and H280A strains for unphosphorylated CsrR). GAS strains were
as follows: GAS M18, the wild-type M18 strain H566; pDL, H566 containing the empty vector pDL278; M1(–), H566 plus pDL_rocAM1 (amino acids 1 to 451); M1_F,
H566 plus pDL_RocAM1_FLAG (amino acids 1 to 451); M3_F, H566 plus pDL_RocAM3_FLAG (amino acids 1 to 416); TMD_F, H566 plus pDL_RocATMD_FLAG (amino acids
1 to 225); and CYT_F, H566 plus pDL_RocACYT_FLAG (amino acids 226 to 451). Numbers beneath the blot indicate the proportions of total CsrR protein that
corresponds to the phosphorylated form by image densitometry analysis.
RocA Binding to CsrS in Group A Streptococcus ®
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detection, multiple copies of RocAM1 with a C-terminal FLAG tag (RocAFLAG) were
expressed from plasmid pDL278 in a serotype M18, RocA-negative strain (Fig. 1). The
resulting strain was designated M1_F (Table 1). A control strain expressing RocAM1
without a FLAG tag [M1(–)] was also generated (Fig. 1B, Table 1). Membrane and
cytosolic fractions of strains M1_F and M1(–) were puriﬁed, and RocA was detected
speciﬁcally in the membrane fraction (Fig. 1B). As reported previously, expression of
full-length RocAM1 in an M18 strain was sufﬁcient to repress capsule expression (26)
(Fig. 1C).
In order to study the separate roles of the RocA transmembrane and cytoplasmic
domains, we generated additional plasmids to express separately the N-terminal TMD
region and the C-terminal cytoplasmic domain. In addition, we generated a plasmid
expressing RocAM3 to allow investigation into the activity of this variant of the RocA
protein. Sequences encoding these domains were cloned into pDL278 with a
C-terminal FLAG tag and transformed into an M18, RocA-negative strain for expression
analysis. The resultant GAS strains were designated M3_F (expressing RocAM3), TMD_F
(expressing RocA amino acids 1 to 225, including all TMDs), and CYT_F (expressing
RocA amino acids 226 to 451, corresponding to the cytoplasmic domain of RocAM1)
(Fig. 1A and B; Table 1). Expression of the N-terminal region, including the TMDs of
RocA from the multicopy plasmid pDL278 (strain TMD_F) was sufﬁcient to restore the
regulatory activity of RocA, as demonstrated by repression of expression of capsular
hyaluronic acid (Fig. 1C), supporting previous reports (27). Regulatory activity appears
to require the TMDs, as expression of the cytoplasmic domain alone from the same
vector did not restore regulatory control (Fig. 1C).
Previous reports have demonstrated that the regulatory activity of RocA is depen-
dent on the expression of functional CsrS (23), whereby RocA enhances the phosphor-
ylation of the response regulator CsrR, promoting the transcriptional repression of
target genes. Based on our observations suggesting that the TMDs of RocA are
sufﬁcient for effective modulation of CsrRS-mediated gene regulation, we expected
that this fragment of RocA would also be sufﬁcient to modulate the phosphorylation
status of CsrR. To test this prediction, we used Phos-tag SDS-PAGE and Western blotting
to assess the levels of phosphorylated CsrR (CsrR-P) in cell lysates puriﬁed from GAS
strains expressing different RocA fragments (Fig. 1D). In this system, Phos-tag reagent
incorporated into the SDS-PAGE gel binds to phosphorylated proteins and retards their
migration, allowing differentiation between the phosphorylated and unphosphorylated
forms of a speciﬁc protein by immunoblotting. Using this approach, we found that GAS
strains expressing RocA fragments that included the TMDs were associated with
increased CsrR phosphorylation compared to that of a strain expressing the RocA
cytoplasmic domain or an empty vector control. Additional controls included CsrS
mutant GAS strains harboring inactivating mutations in the kinase (H280A) (12) or
phosphatase (T284A) domains, which display low and high phosphorylation of CsrR,
respectively (30).
TABLE 1 Bacterial strains used in this study
Strain Description Reference/source
S. pyogenes 854 Wild-type M1 11
S. pyogenes 188 Acapsular mutant of wild-type M3 strain 950771 40
S. pyogenes H566 Wild-type M18 26
L. lactis 1363 Wild type 41
M1(–) H566  pDL_rocAM1 This study
M1_F H566  pDL_rocAM1_FLAG This study
M3_F H566  pDL_rocAM3_FLAG This study
TMD_F H566  pDL_rocATMD_FLAG This study
CYT_F H566  pDL_rocACYT_FLAG This study
854_chF 854 expressing rocAFLAG This study
854_H280A 854 expressing csrSH280A 12
854_T284A 854 expressing csrST284A This study
L_RocAFLAG_CsrSHIS L. lactis  pOri_csrSHIS_rocAFLAG This study
E. coli KDZif1ΔZ -Galactosidase reporter 42
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Results of these experiments indicate that RocA modulates the phosphorylation
status of CsrR and that the TMDs are required for this activity (Fig. 1D). As with the
results for capsule expression, the cytoplasmic domain of RocA alone was not sufﬁcient
to promote high-level phosphorylation of CsrR. These data strongly implicate RocA as
a functional regulator of CsrR phosphorylation.
RocA interacts with CsrS in the streptococcal membrane. Our data suggested
that only the TMD-containing N-terminal region of RocA is essential for regulatory
activity, which has previously been demonstrated to be dependent on the expression
of a functional CsrS (23). While multiple lines of evidence support a role for RocA as an
auxiliary regulator of CsrRS, a mechanism by which such regulation may occur has not
been determined. We hypothesized that RocA and CsrS interact within the streptococ-
cal membrane via the RocA TMDs. To test this hypothesis, we ﬁrst investigated whether
full-length RocA could bind CsrS.
In order to determine whether RocA forms a complex with CsrS in vivo, we
performed coimmunoprecipitation experiments for CsrS and RocA with GAS strain
M1_F expressing RocAFLAG in the bacterial membrane. For these experiments, GAS
membrane fractions were detergent solubilized, and RocAFLAG was puriﬁed by afﬁnity
chromatography using anti-FLAG beads (Fig. 2). Native CsrS protein coeluted with
full-length RocAFLAG from the solubilized membranes of strain M1_F. Importantly, CsrS
was not detected in the eluted fraction from the same immunoprecipitation protocol
performed with the control strain, M1(–), a result that rules out nonspeciﬁc interaction
of CsrS with the anti-FLAG beads (Fig. 2). As a further control for the speciﬁcity of the
binding interaction between RocA and CsrS, a silver-stained gel suggested that RocA-
FLAG and CsrS accounted for nearly all the protein from strain M1_F eluted from the
anti-FLAG afﬁnity resin in the experiment described above (see Fig. S1 in the supple-
mental material).
In order to validate these ﬁndings, we expressed both RocA and CsrS in the
nonpathogenic Gram-positive bacterium Lactococcus lactis (Table 1). This approach
allowed us to overexpress both proteins in a bacterial species in which they play no
functional role and are thus tolerated at high concentrations. RocAFLAG and CsrSHis were
coexpressed from the pOri23 vector. CsrSHis was puriﬁed from detergent-solubilized
membrane preparations using nickel-nitrilotriacetic acid (Ni-NTA) resin. RocA coeluted
with CsrS (Fig. S2), suggesting that the two proteins interact within the bacterial
membrane.
RocA TMDs are essential for intramembrane interaction with CsrS. Having
demonstrated a speciﬁc interaction between RocA and CsrS in the GAS cell membrane,
we investigated which domains of the RocA protein were necessary for this interaction.
Using the panel of GAS strains expressing different FLAG-tagged RocA fragments
FIG 2 RocA interacts directly with CsrS in the GAS cell membrane. RocAFLAG was expressed from plasmid
pDL278 in GAS M18 (M1_F); solubilized membrane preparations (lanes M) were immunoprecipitated
using anti-FLAG beads. SDS-PAGE and immunoblotting of the eluted fraction showed enrichment for
RocAFLAG and speciﬁc coprecipitation of native CsrS in the eluted fraction (lanes E) from strain M1_F but
not from the negative control, M1(–), which expresses RocA without the FLAG tag (red, anti-FLAG; green,
anti-CsrS).
RocA Binding to CsrS in Group A Streptococcus ®
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(Fig. 1B; Table 1), we performed similar pulldown experiments with detergent-
solubilized membrane fractions of strains M3_F and TMD_F (Fig. 3A). RocAM3 and
RocATMD FLAG-tagged protein fragments were puriﬁed by afﬁnity chromatography,
similarly to full-length RocA (Fig. 3B). Following immunoprecipitation of these RocA
fragments, native CsrS protein was detected in the eluted fraction with both RocA
fragments, unlike in identical experiments performed with control strain M1(–) (Fig. 3B).
We therefore conclude that the N-terminal region containing the TMDs of RocA is
sufﬁcient to bind CsrS. As described above, expression of RocATMD was also sufﬁcient
to restore CsrRS-mediated gene regulation (Fig. 1C). Taken together, these results
suggest that the TMDs mediate the functional interaction of RocA with CsrS.
Next, we assessed whether the cytoplasmic domain plays a role in the interaction of
RocA with CsrS. Due to the localization of this region of the protein in the GAS cytosol,
we ﬁrst performed experiments with strain M1_F to conﬁrm that the interaction
observed between full-length RocA and CsrS in puriﬁed membranes (Fig. 3B) was
reproduced when performed using protoplast lysates. In agreement with data from the
solubilized membrane fraction, pulldown of RocAFLAG from the protoplast lysates of
M1_F, but not control strain M1(–), resulted in coprecipitation of native CsrS (Fig. S3).
Accordingly, we performed additional pulldown experiments with the protoplast ly-
sates from GAS strain CYT_F. Native CsrS protein did not coprecipitate with RocACYT
(Fig. S3), indicating that the cytoplasmic domain of RocA does not directly bind CsrS. In
addition, expression of the cytoplasmic domain was not sufﬁcient to restore regulatory
control in a RocA-negative strain (Fig. 1C), an observation that strongly implicates the
interaction of RocATMD with CsrS as critical in the transcriptional regulation of GAS,
possibly by modulation of CsrS kinase activity and consequent phosphorylation of CsrR.
The RocA cytoplasmic domain forms homodimers. Having shown a requirement
for the TMDs in the binding of RocA to CsrS, we sought to ascertain a role for the
cytoplasmic domain. Although predicted to function as a histidine kinase, RocA lacks
certain structural motifs typically associated with kinase activity, and evidence of
enzymatic activity has not been reported for RocA (22). In addition, since RocA requires
functional CsrS in order to exert its regulatory inﬂuence (23) and we have shown the
interaction with CsrS to be essential for activity, it seemed likely that the cytoplasmic
domain plays an important, nonenzymatic role in RocA function. It is also important to
FIG 3 RocA transmembrane domains are sufﬁcient for binding to CsrS. Pulldown experiments of
RocAFLAG fragments with CsrS. (A) Western blot of solubilized membrane preparations of GAS M18
expressing RocAFLAG fragments expressed from plasmid pDL278. (B) Western blot of the eluted fraction
of an anti-FLAG immunoprecipitation showing enrichment for RocAFLAG fragments of full-length M1, M3
(amino acids 1 to 416), and the transmembrane domain (amino acids 1 to 225). Coprecipitation of CsrS
was observed for all RocAFLAG fragments tested (red, anti-FLAG; green, anti-CsrS). See the legend of Fig. 1
for strain designations.
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note that while a multicopy plasmid encoding RocAM3 (or RocATMD) was sufﬁcient to
restore regulatory control to a RocA-negative strain, RocAM3 produced from a single
chromosomal copy of rocAM3, as carried by all M3 isolates sequenced to date, is
functionally inactive (23, 28). The fact that this truncated form of RocA is defective in
its functional interaction with CsrS raised the question of whether the cytoplasmic
domain plays a structural role in RocA’s ability to interact with CsrS. Since many
membrane-associated sensor kinases with a cytoplasmic domain structure similar to
that of RocA form homodimers, which are essential for protein activity (1, 16, 17), we
investigated whether RocA could form homodimers and if the cytoplasmic domain was
involved in the interaction.
To determine whether full-length RocA could form homodimers in GAS, we treated
strains M1(–) and M1_F with formaldehyde, which forms covalent linkages between
proteins within 2 Å of one another. After formaldehyde cross-linking, proteins from
protoplast preparations of these bacteria were separated by SDS-PAGE, subjected to
Western blotting with anti-FLAG antibody to detect RocA, and analyzed for the ap-
pearance of a higher-molecular-weight band corresponding to RocA dimers. A new
dominant band, absent from strain M1(–) and approximately twice the size of a RocA
monomer, was detected in the protoplast lysate of strain M1_F, a result that suggests
strongly that homodimer formation occurs within GAS (Fig. 4A). A less abundant
higher-molecular-weight complex, approximately the predicted size of a RocA tetramer,
was also observed. We also generated a strain of serotype M1 GAS, designated 854_chF,
that contains a single functional chromosomal copy of RocAFLAG (Table 1). Similar
cross-linking experiments were performed using a protoplast lysate from this strain.
Due to the low native expression levels of RocA, RocAFLAG was afﬁnity puriﬁed from
protoplast lysates of 854_chF to allow detection by immunoblotting (Fig. 4B). These
experiments showed that, at native expression levels, RocA forms homodimers within
GAS, suggesting that homodimerization of RocA occurs under physiologic conditions
(Fig. 4B).
We also investigated which domains of RocA were necessary for homodimer for-
mation. Under the same cross-linking conditions described above, RocA fragments
from the protoplast preparations of strains M3_F and CYT_F were also observed to form
homodimers (Fig. 4A). RocA dimers were not observed in TMD_F, which expresses only
the N-terminal portion of RocA containing the transmembrane domains. Together,
results of these experiments indicate that only the cytoplasmic domain is involved in
RocA dimer formation (Fig. 4A). Interestingly, the extent of homodimer formation
observed for RocAM3 appeared less than that of RocAM1, suggesting that dimer
formation may be impaired in serotype M3 GAS, which lacks the C-terminal 35 amino
acids of the cytoplasmic domain (Fig. 4A).
To further validate that the cytoplasmic domain of RocA is sufﬁcient for RocA-RocA
interactions, we utilized a bacterial two-hybrid system. The cytoplasmic domain of
RocAM1 was cloned into two expression vectors as a C-terminal fusion to either the 
subunit of E. coli RNA polymerase or the V-Zif transcription factor (31). When coex-
pressed in an E. coli reporter strain, interaction between RocA fragments activates
transcription from a test promoter containing a V-Zif-binding site. The test promoter is
positioned to drive expression of a linked lacZ reporter gene, which can be quantiﬁed
as -galactosidase activity (31). As anticipated from the cross-linking experiments, data
from these experiments supported the ﬁnding that the RocA cytoplasmic domain forms
homodimers. Taken together, the results suggest that the cytoplasmic domain is both
necessary and sufﬁcient for the formation of RocA homodimers in vivo and likely plays
a role in RocA function (Fig. 4C).
RocAM3 forms aggregates in vivo, which may explain the loss of protein
function. Having observed that the cytoplasmic domain of RocA is necessary for
functional interaction of RocA with CsrS and that homodimer formation may be less
efﬁcient in M3 GAS strains, which express a truncated form of RocA (Fig. 4A), we
hypothesized that impaired dimerization contributes to the loss of RocA activity
observed in M3 GAS strains. However, bacterial two-hybrid assays using RocAM3-CYT
RocA Binding to CsrS in Group A Streptococcus ®
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similar to those described above revealed that the cytoplasmic domain of RocAM3 was
capable of interacting with itself (Fig. 5A), albeit less avidly than the (full-length)
cytoplasmic domain of RocAM1 (Fig. 4C).
To compare the relative afﬁnities of RocAM1 and RocAM3 homodimer interactions,
we puriﬁed recombinant proteins corresponding to the cytoplasmic domains of the
two RocA proteins. We ﬁrst expressed RocAM1, which could be puriﬁed at high
concentration and which remained soluble in aqueous buffers (Fig. 5B). However, under
the same conditions and at a comparable concentration, RocAM3 formed high-
molecular-weight soluble aggregates, as assessed by dynamic light scattering (Fig. 5B).
Aggregation of RocAM3 prevented a direct analysis of the afﬁnity of binding in vitro.
In order to ascertain whether RocAM3 forms aggregates in vivo within M3 GAS, we
performed additional cross-linking experiments to detect such aggregates in the
bacterial cells. SDS-PAGE and Western blotting of protoplast preparations prepared
from GAS cells after formaldehyde cross-linking revealed high-molecular-weight aggre-
gates of RocAM3-FLAG in strain M3_F but not in strain M1_F (expressing full-length
FIG 4 The RocA cytoplasmic domain is necessary for homodimer formation. (A) GAS M18 strains expressing RocAFLAG fragments were subjected to
formaldehyde cross-linking, and then RocA was detected in protoplast preparations by SDS-PAGE and immunoblot probed with anti-FLAG antibody (red
text  monomer; black text  dimer). See Fig. 1 legend for strain designations. (B) Pull-down of RocAFLAG from the protoplast lysate of GAS M1 strain 854 or
854_chF (854 expressing a single chromosomally integrated copy of RocAFLAG). RocA forms homodimers at physiological concentrations within GAS. (C) A
bacterial two-hybrid assay demonstrates the interaction between RocACYT monomers. Contact between RocACYT fused to the  subunit of E. coli RNA
polymerase and RocACYT fused to the V-Zif protein results in transcription activation from the lac operon quantiﬁable by -galactosidase activity (data show
means  standard deviations [SD] of results from 3 independent experiments).
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RocAM1-FLAG) (Fig. 5C). These results are consistent with the protein aggregation
observed in vitro for the recombinantly expressed cytoplasmic domain of RocAM3
compared to that of RocAM1 (Fig. 5B). We speculate that aggregation of RocAM3 may
explain the defective regulation of the CsrRS regulon in M3 isolates, presumably by
impairing the functional interaction of RocAM3 with CsrS.
DISCUSSION
In this study, we demonstrate that RocA is an auxiliary regulator of the CsrRS TCS in
GAS and that RocA and CsrRS collectively form a multicomponent integrated regulatory
system. Using a combination of genetic and biochemical approaches, we show that the
membrane-associated N-terminal region of RocA interacts with CsrS in the bacterial
membrane and is essential for functional regulation of the CsrRS regulon. In addition,
we show that the RocA cytoplasmic domain is necessary for the formation of ho-
modimers, a process suggested to be an important step in RocA’s modulation of CsrRS
function. Finally, we demonstrate that in M3 GAS, truncated RocAM3 forms aggregates,
a process associated with impairment of a functional interaction with CsrS.
Auxiliary regulators are increasingly recognized for the signiﬁcant role that they play
in bacterial gene regulation (16–18). These proteins are distinct from the TCS on which
they act but through direct protein-protein interactions are capable of modulating the
FIG 5 Serotype M3 RocA protein aggregates in vitro and in vivo. (A) A bacterial two-hybrid assay demonstrates the interaction between
RocAM3_CYT monomers. Contact between RocAM3_CYT fused to the  subunit of E. coli RNA polymerase and RocAM3_CYT fused to the V-Zif
protein results in transcription activation from a test promoter driving the expression of a linked lacZ reporter gene, quantiﬁable by
-galactosidase activity (data show means SD of results from 3 independent experiments). (B) Dynamic light-scattering analysis showing
relative molecular sizes of recombinant RocAM1_CYT and RocAM3_CYT proteins. RocAM1_CYT eluted from a Ni-NTA resin column as a soluble
monomer of the expected molecular size, whereas RocAM3_CYT formed large aggregates. d.nm, diameter in nanometers. (C) Protoplast
preparations of a GAS M18 strain expressing FLAG-tagged RocAM1 or RocAM3 after formaldehyde cross-linking. Samples were subjected
to SDS-PAGE, and the immunoblot was probed with anti-FLAG antibody. *, high-molecular-weight aggregates of RocAM3, but not RocAM1.
See the legend of Fig. 1 for strain designations.
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activity of either the sensor kinase (within the sensing, intramembrane, or enzymatic
domains) or the response regulator to ultimately control its phosphorylation state and
regulatory activity (19). Here, we demonstrate binding of RocA to CsrS in vivo and
identify the RocA domains required for functional interaction with the CsrRS TCS.
CsrS is a bifunctional sensor capable of modulating CsrR phosphorylation by both
kinase and phosphatase activity (15, 32). Current models suggest that sensor histidine
kinases dimerize to permit one kinase molecule to phosphorylate the other (33).
Conformational changes in kinase homodimers in response to external ligands or
regulatory proteins mediate autophosphorylation and subsequent phosphotransfer to
the response regulator to modulate its binding to target promoters (33). CsrS is known
to modulate expression of the CsrRS regulon in response to increased extracellular
Mg2 (6) and subinhibitory levels of the cathelicidin LL-37 (11), inducing repression and
derepression, respectively, of most target genes. Here we show that the region of RocA
that includes TMDs interacts with CsrS in the GAS membrane, and we hypothesize that
the consequence of this interaction is to modulate the conformation of CsrS and its
subsequent phosphorylation or dephosphorylation of CsrR. RocA enhances transcrip-
tional repression of target genes by increasing the abundance of phosphorylated CsrR,
suggesting that RocA interactions with CsrS enhance its kinase activity or inhibit its
phosphatase activity (23, 24).
Deletion of rocA has been shown to impair the GAS response to LL-37 (27). While it
is possible that RocA is actively involved in detecting extracellular LL-37 levels, since
RocA has no extracellular sensing domain, it seems more likely that, in the absence of
RocA, CsrS kinase activity is tonically inhibited or that its phosphatase activity is
enhanced, mimicking the LL-37 response (14). LL-37 binding to CsrS may counteract
the effect of RocA, allowing the bacteria to respond rapidly to changing environments.
In support of this hypothesis is the observation that LL-37 regulation of the CsrRS
regulon in serotype M3 GAS is less marked than that observed for other serotypes
believed to express functional RocA protein (6).
GAS strains isolated from patients with invasive infection are frequently associated
with function-altering mutations in CsrS or CsrR (7, 34). However, such mutations are
rare among noninvasive throat isolates, and experimental studies suggest that they are
deleterious for colonization of the host skin and oropharynx (35). Mutations in RocA
have also been observed in clinical disease isolates and are associated with enhanced
virulence (25, 36, 37). A recent study showed that the rocA gene in serotype M28 GAS
is unusually polymorphic, with a signiﬁcantly higher frequency of mutation than in
other serotypes (25). The majority of mutations were identiﬁed within the N-terminal
TMDs of RocA, which we show are both necessary and sufﬁcient for interactions with
CsrS. Serotype-speciﬁc mutations resulting in truncated, nonfunctional RocA have also
been reported for M3 and M18 GAS (23, 26, 28). Mutations in RocA are therefore not
necessarily deleterious to the bacterium and have been shown to underlie increased
virulence factor expression and infection syndromes associated with these serotypes.
The serotype M18 truncation in RocA occurs at amino acid 29 of 451 (26). In contrast,
the serotype M3 truncation occurs at amino acid 416 of 451, generating a large
fragment of RocA protein (28). The RocAM3 protein has been shown to be nonfunc-
tional when it is expressed from the GAS chromosome at physiological levels (23). Our
ﬁnding, supporting a previous report (27), that the RocA TMDs (amino acids 1 to 225)
are sufﬁcient for a functional interaction with CsrS raised the question as to how the M3
truncation impacts RocA activity. Subsequent cross-linking experiments wtih GAS and
bacterial two-hybrid assays with E. coli revealed that the cytoplasmic domain of RocA
is both necessary and sufﬁcient for homodimer formation and that dimerization is likely
important for RocA activity at physiological expression levels. Interestingly, the trun-
cated serotype M3 cytoplasmic domain was also able to form homodimers, albeit less
efﬁciently than the full-length cytoplasmic domain of the M1 RocA protein. Subsequent
experiments demonstrated that RocAM3 forms aggregates within GAS, which we
hypothesize contributes to the loss of function of RocA in serotype M3 GAS, due to
impaired homodimer formation and the loss of a functional interaction with CsrS.
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Homologs of RocA have not been described for other bacterial species despite the
fact that CsrRS homologs are expressed in a number of other streptococci, the best
studied of which is that expressed by the human pathogen group B Streptococcus (GBS)
(38, 39). Interestingly, Abx1, a membrane protein with eight TMDs, has been shown to
modulate the activity of CsrS in GBS. In contrast to RocA, Abx1 acts to reduce the
abundance of phosphorylated CsrR to derepress virulence factor production (16). Abx1
has also been shown to interact directly with the TMDs of GBS CsrS, suggesting that this
may be a common theme in the modulation of CsrS activity (16). Abx1 is also capable
of forming homodimers; however, the effect of dimerization on gene regulation has not
been reported. The variation in auxiliary regulators may allow a controlled response to
external stimuli within the varied host niches inhabited by different streptococcal
species.
In this study, we have demonstrated that RocA acts as an auxiliary regulator of the
GAS TCS CsrRS and that RocA and CsrS interact in the bacterial membrane to modulate
the phosphorylation state of the response regulator CsrR. The evidence presented
supports a direct interaction between an auxiliary regulatory protein and CsrS, the
activity of which is also regulated by Mg2 and LL-37. The relative kinase/phosphatase
activity of CsrS is thus the result of the integration of environmental signals and input
from RocA that together result in a complex regulatory system critical for GAS coloni-
zation and infection in the human host.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains used for molecular manipulation were GAS
854, an M1 strain isolated from a patient with a retroperitoneal abscess (11), GAS 188, an isogenic
acapsular derivative of M3 strain 950771 (40) and H566, an M18 strain isolated from a patient with
streptococcal toxic shock syndrome (26). All strains used are listed in Table 1. GAS were cultured on
Trypticase soy agar supplemented with 5% deﬁbrinated sheep blood (Remel) or Todd-Hewitt (TH) agar
or in TH yeast (THY) broth at 37°C in the presence of 5% CO2. E. coli strain NEB5 (New England Biolabs)
was used for cloning and BL21(DE3) (New England Biolabs) for recombinant protein expression. E. coli
was cultured in LB broth (Sigma). Lactococcus lactis subsp. cremoris 1363 was grown at 30°C in GM17
broth or on GM17 agar (41). Growth media were supplemented with antibiotics where appropriate at the
following concentrations: for E. coli, spectinomycin at 50 g/ml, erythromycin at 500 g/ml, kanamycin
at 30 g/ml, and tetracycline at 10 g/ml; for GAS, spectinomycin at 100 g/ml and erythromycin at
1 g/ml; and for L. lactis, erythromycin at 5 g/ml.
Generation of GAS strains expressing RocA fragments. The rocAM1 sequence was ampliﬁed by
PCR from genomic DNA extracted from strain 854 and cloned into the vector pDL278 as described
previously (26). A FLAG tag was incorporated immediately upstream of the rocA stop codon by overlap
PCR using primers pDLrocAFLAG_F and _R (Table 2), which incorporate XmaJI sites into both ends of the
PCR product. The resulting product was digested with XmaJI and DpnI (Thermo Scientiﬁc) to cleave
residual methylated template plasmid and ligated using T4 ligase (Thermo Scientiﬁc). The resulting
construct was designated pDL_rocAM1FLAG.
The rocAM3 sequence was ampliﬁed from genomic DNA extracted from strain 188 using primers
pDL_rocAM3_F and _R (Table 2) and cloned into the vector pDL278 using restriction enzyme BamHI
(Thermo Scientiﬁc) and T4 ligase (Thermo Scientiﬁc). The resulting construct was designated
pDL_rocAM3FLAG.
Plasmid pDL_rocATMD_FLAG, expressing the N-terminal RocA TMDs, was generated from plasmid
pDLrocAM1_FLAG by overlap PCR. The entire plasmid was ampliﬁed using primers pDL_rocATMD_FLAG_F and
_R (Table 2) to incorporate a stop codon at amino acid 226 and XmaJI restriction sites at both ends of
the amplicon. The resulting PCR product was digested with XmaJI and DpnI (Thermo Scientiﬁc) to cleave
residual methylated template plasmid and ligated using T4 ligase (Thermo Scientiﬁc).
Plasmid pDL_rocACYT_FLAG, expressing the C-terminal RocA cytoplasmic domain was generated from
plasmid pDLrocAM1_FLAG by overlap PCR. Primers pDL_rocACYT_FLAG_F and _R (Table 2) were used to
amplify pDLrocAM1_FLAG and remove amino acids 1 to 225 of the rocA gene product from the resulting
PCR product. NdeI restriction sites were incorporated into both ends of the amplicon, providing a new,
in-frame start codon for expression of RocACYT_FLAG in vivo. The resulting PCR product was digested with
NdeI and DpnI (Thermo Scientiﬁc) to cleave residual methylated template plasmid and ligated using T4
ligase (Thermo Scientiﬁc).
All resulting plasmids were transformed into GAS strain H566 by electroporation as described
previously (26).
Allelic-exchange mutagenesis. Using the temperature-sensitive E. coli-GAS shuttle vector pJRS233
(42), plasmid pJRS_rocAFLAG was generated to facilitate creation of an isogenic GAS-M1 strain expressing
a single, native chromosomal copy of rocA with a FLAG tag. Primers chFLAG_1F and _R (Table 2) were
used to amplify rocA from genomic DNA puriﬁed from M1 strain 854 and to incorporate a C-terminal
FLAG tag into the PCR product (sequence, GACTACAAAGACGATGACGACAAG) directly upstream of the
native stop codon, generating amplicon ch1. Primers chFLAG_2F and _R (Table 2) were used to amplify
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a second PCR product (ch2) that overlaps ch1. Splicing by overlap extension (SOEing) PCR, using
overlapping amplicons ch1 and ch2 as target DNA, was performed using primers chFLAG_1F and
chFLAG_2R (Table 2), incorporating the restriction sites BamHI and SalI into the resulting PCR product to
facilitate cloning into the vector pJRS233. The resulting shuttle vector pJRS_rocAFLAG was transformed
into GAS-M1 strain 854 by electroporation (26), and rocAFLAG was exchanged with the chromosomal copy
of rocA by allelic-exchange mutagenesis (43). Sanger sequencing was performed to conﬁrm introduction
of the FLAG tag into the chromosomal rocAM1 gene.
pJRS233 was also used to generate an isogenic GAS-M1 strain expressing a single, native chromo-
somal copy of csrS with a single mutation at nucleotide 852 (A to G), resulting in a nonsynonymous
mutation from threonine to alanine at amino acid 284. Plasmid pJRS_csrST284A was generated by SOEing
PCR. Overlapping amplicons were generated from genomic DNA puriﬁed from M1 strain 854 using
primer pairs BamHI-csrS-5=/CsrS T284A R and CsrS T284A F/csrS-ID-3=-SalI (Table 2) to incorporate the
A852G nucleotide change into the csrS gene. SOEing PCR, using the overlapping amplicons as target
DNA, was performed using primers BamHI-csrS-5= and csrS-ID-3=-SalI (Table 2), incorporating the restric-
tion sites BamHI and SalI into the resulting PCR product to facilitate cloning into the vector pJRS233. The
resulting plasmid, pJRS_csrSH284A, was transformed into GAS-M1 strain 854 by electroporation (26).
csrSH284A was exchanged with the chromosomal copy of csrS by allelic-exchange mutagenesis as
described previously (43) and conﬁrmed by Sanger sequencing.
Generation of L. lactis coexpressing CsrSHis and RocAFLAG. A DNA fragment containing csrSHis and
rocAFLAG was generated by SOEing PCR and cloned into the vector pOri23, an E. coli Gram-positive shuttle
vector (41) provided by June Scott (44). Brieﬂy, primers L_csrS_F R and L_rocA_F R (Table 2) were
used to amplify overlapping PCR products containing csrS6His and rocAFLAG. Using these two amplicons
as target DNA, SOEing PCR was performed with primers L_csrS_F and L_rocA_R_PstI (Table 2) to generate
a single amplicon containing csrS6His and rocAFLAG and incorporate BamHI and PstI restriction sites. The
resulting amplicon was then cloned into the vector pOri23 to generate pOri23_csrSHisrocAFLAG and
transformed into L. lactis as described previously (45).
Recombinant RocA expression. The predicted cytoplasmic domains of RocAM1 and RocAM3 were
ampliﬁed from strain 854 and 188 genomic DNA using primer pET_ATPase_NcoI_F with reverse primers
M1_pET_ATPase_HIS_R and M3_pET_ATPase_HIS_R, respectively (Table 2). The resulting PCR products
were cloned into the vector pET19b (Novagen), facilitated by incorporation of NcoI and BamHI restriction
sites. Restriction digestion with NcoI and BamHI resulted in removal of the N-terminal His tag included
within the plasmid. The reverse primers incorporated a C-terminal His tag within recombinant RocA. The
resulting constructs, designated pET19b_RocAM1 and pET19b_RocAM3, were transformed into BL21 cells
for recombinant protein expression.
Transformants were initially cultured to an A600 of 0.3 at 37°C and then to an A600 of 0.5 at 20°C.
Protein expression was induced at 20°C using 0.5 mM isopropyl--D-thiogalactopyranoside (IPTG) for 3 h.
Cells were harvested by centrifugation, lysed in lysis buffer [20 mM Tris, 200 mM NaCl, 10% glycerol,
1 mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), 20 mM imidazole] supplemented with pro-
TABLE 2 Primers used in this study
Primer name Sequence 5=–3=a
pDLrocAFLAG_F GGCCCTAGGTGATGTTAAAGGTATGAA
pDLrocAFLAG_R GGCCCTAGGCTTGTCGTCATCGTCTTTGTAGTCGTCAGGCTTAGCTATTTC
pDL_rocAM3_F CGGGATCCTTGCAAAAACTGTAGGCTGTG
pDL_rocAM3_R CGGGATCCTTACTTGTCGTCATCGTCTTTGTAGTCAGTCAAATTGCCAGTC
pDL_rocATMD_FLAG_F GGCCCTAGGTGAAACTCTATTGAGGCAATTG
pDL_rocATMD_FLAG_R GGCCCTAGGCTTGTCGTCATCGTCTTTGTAGTCTTGTTTTACATAACGCTC
pDL_rocACYT_FLAG_F GGAATTCCATATGAACTCTATTGAGGCAATTGTGC
pDL_rocACYT_FLAG_R GGAATTCCATATGTTATCCTTCTCCTTCTCGTTC
chFLAG_1F CGGGATCCGAATGCTGAAAAGAATAATGC
chFLAG_1R TCACCTAGGCTTGTCGTCATCG
chFLAG_2F GATGACGACAAGCCTAGGTGATGTTAAAGGTATGAA
chFLAG_2R CGCCGTCGACCCCAACACCTGAAGCCCAGTG
L_csrS_F CGGGATCCGAAAATCGAGATGTGATAA
L_csrS_R CTCACGAATAACGTATCACCTAGGCTTGTCGTCATC
L_rocA_F GACAAGCCTAGGTGATACGTTATTCGTGAGAAATA
L_rocA_R CTAATGATGATGATGATGATGCTCTCTTTAGACTGGGCC
L_rocA_R_PstI CGCCCTGCAGCTAATGATGATGATGATG
pET_ATPase_NcoI_F CATGCCATGGAAAAGAATAATGCTAAAGATG
M1_pET_ATPase_HIS_R CGGGATCCTCAATGATGATGATGATGATGGTCAGGCTTAGCTATTTC
M3_pET_ATPase_HIS_R CGGGATCCTCAATGATGATGATGATGATGAGTCAAATTGCCAGTCATC
RocA2H_F AAGGAAAAAAGCGGCCGCAAACTCTATTGAGGCAATTGTGC
RocA2H_R CGGGATCCTCAGTCAGGCTTAGCTATTTC
M3RocA2H_R CGGGATCCTTAAGTCAAATTGCCAGTCAT
CsrS T284A F CATGAATTACGAGCGCCGGTTGCG
CsrS T284A R CGCAACCGGCGCTCGTAATTCATG
BamHI-csrS-5’ CCCCGGATCCATGGAAAATCAGAAACAAAAACAG
csrS-ID-3’-SalI CCCCGTCGACTTACTAACTCTCTTTAGACTGGGC
aBold with underlining indicates restriction endonuclease sites.
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tease inhibitor cocktail (GE Healthcare) lysozyme (1 mg/ml) and DNase I (0.05 mg/ml) and subjected to
sonication (Sonic Dismembrator; Thermo Scientiﬁc). Lysates were ﬁltered with a 0.2-m-pore-size ﬁlter
and puriﬁed over Ni-NTA resin (1-ml resin bed). The resin was washed with 20 column volumes of lysis
buffer without protease inhibitors and eluted with 350 mM imidazole in the same buffer. Puriﬁed
proteins were subjected to dynamic light scattering analysis (Malvern).
Capsule quantiﬁcation. GAS strains were cultured in Todd-Hewitt broth (THB) and capsule quan-
tiﬁed as described previously (26) using the hyaluronan DuoSet (R&D).
Preparation of bacterial protoplasts and cell fractions. (i) Preparation of protoplasts. GAS
(180 ml/strain) or L. lactis (90 ml/strain) were cultured to an A600 of 0.4 and pelleted, and cell walls
were digested in 44 ml 10 mM Tris supplemented with 30% rafﬁnose, mutanolysin (100 units/ml)
(Sigma), lysozyme (1 mg/ml) and protease inhibitor cocktail (1:100) (Calbiochem) for 1 h at 37°C.
Samples were centrifuged at 4°C, and pellets containing protoplasts were harvested and stored at
20°C.
(ii) Preparation of protoplast lysates. Frozen protoplasts were resuspended in 1 ml TBS150 (50 mM
Tris, 150 mM NaCl, pH 7.4) and subjected to sonication (Bioruptor) for 5 cycles (5 min; 30 s on, 30 s off).
Cellular debris was removed by centrifugation (20,000 g, 30 min, 4°C). The resulting supernatants were
either incubated in 1-ml aliquots with anti-FLAG magnetic beads (Sigma) (50 l beads/1 ml lysate) at 4°C
overnight, with rotation, or ﬁltered with a 0.2-m-pore-size ﬁlter and further processed for membrane
preparation.
(iii) Preparation of membrane and cytosolic fractions. Membranes were pelleted by ultracentrif-
ugation (150,000 g, 2 h, 4°C). Supernatants constituted the cytosolic fraction. Membrane pellets were
homogenized in ice-cold TBS150 and solubilized in 1% n-dodecyl--D-maltoside (DDM) on ice (1 h).
Samples were diluted 1:4 in ice-cold TBS150 and incubated in 1-ml aliquots with anti-FLAG magnetic
beads (Sigma) (50 l beads/1 ml membrane preparation) overnight (4°C, with rotation).
Immunoprecipitation of RocAFLAG. Following overnight incubation, RocAFLAG was immunoprecipi-
tated from cytoplasmic and membrane preparations according to the manufacturer’s instructions, with
some minor modiﬁcations. Anti-FLAG beads were washed 3 times (4°C, 15 min with rotation in TBS500
[50 mM Tris, 500 mM NaCl, pH 7.4]), supplemented with 0.1% NP-40 (for protoplast preparations) or 0.1%
DDM (for membrane preparations), and RocAFLAG eluted with 3 FLAG in the same buffers. Eluted
fractions were concentrated 20 using 10-kDa spin columns (Thermo Scientiﬁc) and subjected to
SDS-PAGE and Western blotting.
Afﬁnity puriﬁcation of CsrSHis. Membrane preparations were puriﬁed over Ni-NTA resin (1-ml resin
bed). The resin was washed with 2.5-ml column volumes of lysis buffer supplemented with 0.1% DDM,
centrifuged (100 g, 2 min, 4°C) to remove any unbound protein, and resuspended in 5 ml of the same
buffer. Resin was allowed to settle and washed with 10 column volumes of lysis buffer. Bound CsrSHis was
eluted with 500 mM imidazole in the same buffer. Eluted fractions were concentrated 10 using 10-kDa
spin columns (Thermo Scientiﬁc) and subjected to SDS-PAGE and Western blotting.
Cross-linking of GAS proteins in vivo. GAS strains were cultured to an A600 of 0.4 and incubated
with 1% formaldehyde (10 min, room temperature, with rotation) prior to addition of 250 mM glycine to
quench residual formaldehyde (20 min, room temperature, with rotation). Pellets were washed twice in
phosphate-buffered saline (PBS) and protoplast preparations puriﬁed as described above. Samples were
subjected to SDS-PAGE and Western blotting.
SDS-PAGE and Western blotting. For SDS-PAGE, samples were denatured with 100 mM dithiothre-
itol (DTT) and 1 Laemmli buffer. Proteins were fractionated on either 4 to 12% NuPAGE Novex Bis-Tris
gels or 7% NuPAGE Tris-acetate gels (Thermo Scientiﬁc). Proteins were transferred onto nitrocellulose
membranes (Thermo Scientiﬁc), blocked (5% skim milk powder; Sigma), and probed with anti-FLAG
(Sigma), anti-CsrS (6, 12), or anti-His (Abcam) antibodies. Proteins were visualized and analyzed using an
Odyssey infrared imaging system (LI-COR, Lincoln, NE) and Image Studio software monitoring incubation
with ﬂuorescent secondary antibodies (Thermo Scientiﬁc).
Detection of phosphorylated CsrR protein in GAS. GAS strains were cultured to an A600 of 0.5 in
10 ml THY broth supplemented with 30 g/ml hyaluronidase and harvested by centrifugation. Bacterial
lysates were prepared rapidly by bead beating them (twice for 16 s) in ice-cold PBS. All samples were kept
chilled to minimize spontaneous dephosphorylation. Dephosphorylated control samples were prepared
by heating them to 95°C for 10 min. Samples were fractionated by SDS-PAGE on 10% acrylamide gels
supplemented with Phos-tag reagent (Wako) in electrode buffer (25 mM Tris, 192 mM glycine, 0.1% SDS)
at 150 V for 2 h. Gels were washed in transfer buffer (Thermo Scientiﬁc) twice but ﬁrst supplemented with
1 mM EDTA. Western blotting was then performed as described above, and blots were probed with
anti-CsrR antiserum (12). Relative abundances of CsrR protein were quantiﬁed using Image Studio
software.
Bacterial two-hybrid assays. The C-terminal fragments of rocAM1 and rocAM3 gene products
were ampliﬁed by PCR with primer RocA2H_F paired with RocA2H_R and M3RocA2H_R, respectively.
The restriction sites NotI and BamHI were incorporated to facilitate cloning in-frame into the vectors
pACTR--GP and pBR-V-Zif-AP as described previously (31). The resulting vectors were transformed
into E. coli strain KDZif1ΔZ, and protein interactions were assessed by -galactosidase assay (46).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01495-19.
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FIG S1, PDF ﬁle, 0.5 MB.
FIG S2, PDF ﬁle, 0.1 MB.
FIG S3, PDF ﬁle, 0.4 MB.
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